Archives
-
ATF4, H2S, and Doxorubicin Cardiomyopathy
2026-09-16
This preprint identifies an ATF4–CSE–H2S pathway that limits oxidative stress and apoptosis during doxorubicin-induced cardiomyopathy. Its combination of genetic mouse models, AAV9-mediated cardiac overexpression, transcriptomics, and transcriptional validation provides a mechanistic framework for studying cardiotoxicity alongside cancer chemotherapy research.
-
From Abscission Biology to Translational qPCR
2026-09-16
Mechanistic studies of Actinidia arguta fruit abscission show how hormone balance and cell-wall remodeling can guide more rigorous gene expression workflows. This thought-leadership article connects those findings with strategic qPCR design using HotStart™ Universal 2X FAST Green qPCR Master Mix (Rox), while clarifying the boundaries between biological discovery, assay validation, and translational interpretation.
-
Ruxolitinib–oHSV Therapy in Murine Sarcoma
2026-09-15
This study introduces a 46-parameter spectral flow cytometry panel to examine immune responses in murine malignant peripheral nerve sheath tumors treated with Ruxolitinib and repeated oncolytic herpes simplex virus dosing. The approach revealed coordinated changes in CD4 T-cell function, germinal center B cells, and additional myeloid and lymphoid compartments that were difficult to resolve with conventional flow cytometry.
-
TaqI Restriction Endonuclease: Practical Digestion Guide
2026-09-15
TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the TCGA recognition site, producing sticky ends for downstream molecular biology workflows. It is intended for research use only and should not be used for diagnostic, clinical, or medical applications.
-
NAT10–OGA ac4C Control of Oocyte Maturation
2026-09-14
Lin et al. identify OGA mRNA as a functional target of NAT10-mediated N4-acetylcytidine (ac4C) modification during mouse oocyte maturation. Their findings connect RNA modification, transcript stability, and O-GlcNAc signaling, providing a mechanistic framework for understanding—and potentially improving—in vitro maturation workflows.
-
RNase R and the Translational Logic of circRNA
2026-09-14
Circular RNA research is moving from cataloging candidates to testing causal mechanisms. This article explains how selective linear RNA digestion with Ribonuclease R can strengthen validation of the circ_0042103/TAF15/NER axis in pulpitis while clarifying workflow controls, translational limits, and strategic opportunities.
-
TaqI Restriction Endonuclease Protocol Guide
2026-09-13
TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA containing the 5′-TCGA-3′ recognition site. It is intended for research workflows such as cloning and gel-based DNA analysis, not diagnostic, clinical, or medical applications.
-
Recombinant Human Oncostatin M in Neuroimmune Assays
2026-09-12
Recombinant Human Oncostatin M can serve as a controlled cytokine perturbation for dissecting receptor-dependent cell behavior. This article connects OSM assay design with recent causal neuroimmune research while defining practical limits for translating findings across model systems.
-
Bovine Insulin for Stem Cell Culture Workflows
2026-09-11
Bovine insulin supports controlled studies of cell proliferation, metabolism, and senescence rather than serving as a generic medium additive. This workflow pairs insulin titration with the Biodentine–hDPSC model to separate metabolic support from material-driven Wnt/β-catenin effects.
-
BI 2536: A Practical PLK1 Inhibitor Workflow
2026-09-11
BI 2536 provides a selective way to connect PLK1 activity with mitotic checkpoint control, G2/M arrest, and apoptosis. This workflow shows how to move from dose-response profiling to p31comet mechanism assays and tumor-model interpretation while avoiding common handling and endpoint errors.
-
Macrophage EP4 Loss Accelerates Atherosclerosis
2026-09-10
The reference study identifies macrophage EP4 deficiency as a driver of atherosclerosis progression, linking loss of EP4 signaling to CD36-dependent lipid uptake, foam cell formation, M1 polarization, and plaque destabilization. Its combination of conditional mouse genetics, cellular experiments, transcriptomics, proteomics, qPCR, and immunoblotting provides a mechanistic framework for studying inflammatory lipid disease in vivo.
-
Bifendate (DDB): Applied Liver Research Workflows
2026-09-10
Bifendate (DDB) combines hepatoprotection, lipid-metabolism control, and multi-step autophagy modulation in a single research workflow. This guide shows how to build reproducible cell, hepatocyte, and animal studies while separating direct CYP3A4 modulation from true enzyme induction.
-
ATS-9R for FAM83A Adipocyte Studies
2026-09-09
ATS-9R enables targeted gene silencing in white adipose tissue and provides a practical route for testing FAM83A-dependent adipocyte biology. This article connects Prohibitin-mediated delivery with assay design, mitochondrial interpretation, and translational obesity research.
-
Bsa I (RNase-free): Practical DNA Workflow
2026-09-09
Bsa I (RNase-free) is a sequence-specific DNA cleavage enzyme for molecular biology research, including gene cloning and recombinant DNA workflows where RNA contamination should be minimized. It is supplied with 10X Cut rA Buffer for research use only and should not be used for diagnostic, clinical, or medical applications.
-
From SPI1 Biology to Reproducible NSCLC qRT-PCR
2026-09-08
The SPI1/miR-616-5p axis offers a compelling NSCLC metastasis model, but translating that mechanism depends on rigorous RNA measurement. This thought-leadership guide connects the 2026 iScience findings with reproducible cDNA synthesis, qRT-PCR design, and translational assay strategy using HyperScript™ RT SuperMix for qPCR.